NASDAQ:CVAC
CureVac
- Stock
locale
Germany
market
STOCKSindustry
Biotechnologywebsite
www.curevac.comipo date
Aug 14, 2020
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical tr...Show More
Earnings
Earnings Release in 19 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus